NASOPHARYNGEAL CANCINOMA (NPC)
Clinical trials for NASOPHARYNGEAL CANCINOMA (NPC) explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CANCINOMA (NPC) trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CANCINOMA (NPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo tested in battle against advanced throat cancer
Disease control Not yet recruitingThis study is testing a new two-drug combination as the first treatment for people with advanced nasopharyngeal cancer that has come back or spread. It aims to see if the treatment can control the cancer for longer and is safe for patients. The trial will enroll about 30 adults w…
Matched conditions: NASOPHARYNGEAL CANCINOMA (NPC)
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New trial aims to boost survival in recurrent nasopharyngeal cancer with surgery and drug combo
Disease control Not yet recruitingThis study is testing a combination treatment for people whose nasopharyngeal cancer has come back in the original area. Participants will receive a drug (pembrolizumab) and chemotherapy before surgery to remove the tumor, followed by more of the drug after surgery. The goal is t…
Matched conditions: NASOPHARYNGEAL CANCINOMA (NPC)
Phase: PHASE2 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Three-Pronged attack on tough head & neck cancer
Disease control Not yet recruitingThis study is testing whether adding a special type of low-dose radiation to a standard chemotherapy and immunotherapy combination can better control advanced nasopharyngeal cancer that has returned or spread. It will involve about 55 adults with this specific type of head and ne…
Matched conditions: NASOPHARYNGEAL CANCINOMA (NPC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New combo therapy aims to keep advanced throat cancer at bay
Disease control Not yet recruitingThis trial is for people with advanced nasopharyngeal cancer (a type of throat cancer) that hasn't fully responded to initial chemotherapy. It will test if adding a chemotherapy pill (capecitabine) to an immunotherapy drug (adebrelimab) for a year after standard treatment is bett…
Matched conditions: NASOPHARYNGEAL CANCINOMA (NPC)
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Cancer trial tests if less treatment is just as good
Disease control Not yet recruitingThis study is testing if a shorter treatment schedule with the immunotherapy drug tislelizumab, combined with standard chemotherapy and radiation, works as well as the standard, longer schedule for people with advanced nasopharyngeal cancer. It will involve about 418 adults to se…
Matched conditions: NASOPHARYNGEAL CANCINOMA (NPC)
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo trial aims to tame aggressive nasal cancer
Disease control Not yet recruitingThis study is testing whether adding the drug anlotinib to the current standard treatment (immunotherapy plus chemotherapy and radiation) works better for people with high-risk, locally advanced nasopharyngeal cancer. It will enroll 412 adults to compare the two treatment approac…
Matched conditions: NASOPHARYNGEAL CANCINOMA (NPC)
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC